United States· US:62032-106_83215733-be55-48e1-95dc-2884132042d2
OBAGI C RX system C CLARIFYING SERUM
A hydroquinone product containing hydroquinone, registered in United States by Obagi Cosmeceuticals LLC. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Hydroquinone is registered in 5 of 19 countries.
Countries holding a registration under ATC D11AX11 (hydroquinone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Hydroquinone · ATC D11AX11
5 / 19 countries
- Canada
- Germany
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYDROQUINONE
- Manufacturer
- Obagi Cosmeceuticals LLC
- Country
- United States (US)
- ATC code
- D11AX11
- ATC class
- Hydroquinone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162032-106-10
- ndc1162032106101 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydroquinone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEldoquin 2% creamCrawford Healthcare Ltd
- SpainHQUIN 40 MG/G CREMAGalenicum Derma S.L.U.
- CanadaERFA HYDROQUINONESEARCHLIGHT PHARMA INC
- GermanyHydrochinon Smartpractice EuropeSmartpractice Europe Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Hydrochinon Smartpractice Europe
- Spain · Hquin, Licoforte
- United Kingdom (Northern Ireland) · Symba
- Portugal · Hidrospot, Quinostasa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f320f984-8c2c-4613-a504-ccb627eeccdf GET /v1/drugs/f320f984-8c2c-4613-a504-ccb627eeccdf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "40",
"substance": "HYDROQUINONE",
"productndc": "62032-106",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about hydroquinone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.